NeuroPace (NPCE) Invested Capital (2020 - 2021)

NeuroPace (NPCE) posted quarterly Invested Capital of $3.6 million for Q1 2021, up 75.72% quarter-over-quarter from $2.0 million in Q4 2020.

NeuroPace (NPCE) Invested Capital (2020 - 2021) Analysis & Trends

NeuroPace's Invested Capital history runs 2 years deep, the most recent figure standing at $3.6 million for Q1 2021.

In Q1 2021, Invested Capital changed N/A year-over-year to $3.6 million; the TTM figure through Dec 2021 stood at $3.6 million (up 75.72% YoY), while the FY2020 annual figure was $2.0 million, changed N/A from the prior year.
Invested Capital for Q1 2021 stood at $3.6 million, up from $2.0 million in the prior quarter.
The five-year high for Invested Capital was $3.6 million in Q1 2021, with the low at $2.0 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn	3.01 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn	750.00 Mn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn	1.79 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn	1.71 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn	-
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn	2.00 Mn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn	1.34 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn	243.40 Mn
10	NeuroPace	478.49 Mn	426.79 Mn	18.91 Mn	-

Download Data

Date	Value
Mar 31, 2021	3.59 Mn
Dec 31, 2020	2.04 Mn